CLARIFICATION NOTE – IMI IP POLICY Objectives – clarify why IMI Intellectual Property (IP) policy is distinct from the FP7 IP rules The Innovative Medicines Initiative (IMI) (established by Council Regulation (EC) No - Initiative for Science in Europe - Document - PDFSEARCH.IO

First Page	Meta Content
	CLARIFICATION NOTE – IMI IP POLICY Objectives – clarify why IMI Intellectual Property (IP) policy is distinct from the FP7 IP rules The Innovative Medicines Initiative (IMI) (established by Council Regulation (EC) No Add to Reading List Document Date: 2010-09-20 06:34:39 Open Document File Size: 148,07 KB Share Result on Facebook Continent Europe / / Event Product Issues / / IndustryTerm pharmaceutical products / given technology / drug product / biopharmaceutical sector / imaging / recombinant production tool / pharmaceutical sector / / Organization IMI IP / European Union / Executive Office / / Product nucleotide / / PublishedMedium the FP7 IPR guide / / Technology given technology / drug discovery / drug development / / SocialTag Framework Programmes for Research and Technological Development FP7 Innovative Medicines Initiative Pharmaceutical industry Science and technology in Europe

CLARIFICATION NOTE – IMI IP POLICY Objectives – clarify why IMI Intellectual Property (IP) policy is distinct from the FP7 IP rules The Innovative Medicines Initiative (IMI) (established by Council Regulation (EC) NoAdd to Reading List